ISAL 2019 | Histamine dihydrochloride and IL-2 for AML: impacts for relapse risk and survival

Name: Histamine dihydrochloride and IL-2 for AML: impacts for relapse risk and survival
Uploaded: 2019-02-25T00:00:00.000Z
Duration: 1 min 50 s
Description: Anna Martner, PhD, of the University of Gothenburg, Gothenburg, Sweden, discusses the mechanism of action of the combination of histamine dihydrochloride and IL-2, and its impacts for relapse risk and survival in acute myeloid leukemia (AML). This interview was held at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.

Anna Martner • 25 Feb 2019

ISAL 2019

Acute Myeloid Leukemia Leukemia Histamine dihydrochloride IL-2

Anna Martner, PhD, of the University of Gothenburg, Gothenburg, Sweden, discusses the mechanism of action of the combination of histamine dihydrochloride and IL-2, and its impacts for relapse risk and survival in acute myeloid leukemia (AML). This interview was held at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.